Latest news for Investcorp India (NASDAQ:IVCA) Stock

Investcorp India Acquisition Corp is a newly organized blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Investcorp India Acquisition Corp. - Class A Ordinary Shares

Investcorp India Acquisition Corp

Investcorp India Acquisition Corp. - Unit

Investcorp India Acquisition Corp. - Warrant

TD Cowen analyst Robert Moskow maintains McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) with a Hold and raises the price target from $84 to $86.

News

Price Target

Analyst Ratings

TD Cowen Maintains Hold on McCormick & Co, Raises Price Target to $86

Raymond James analyst Ric Prentiss downgrades T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) from Strong Buy to Outperform and raises the price target from $208 to $221.

Downgrades

TMUS

Raymond James Downgrades T-Mobile US to Outperform, Raises Price Target to $221

Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading slightly lower on Wednesday.</a>
The auto behemoth reported&nbsp;total U.S. sales of 305,294 vehicles in the third quarter of 2024, down 20% year over year.
&#8220;At the beginning of Q3, we introduced an aggressive incentive program across our U.S. brand portfolio that with significant competitive updates made in August and September resulted in the reduction of dealer inventory by over 50,000 units through the end of the quarter, down 11.6%,&#8221; said&nbsp;Matt Thompson, head of U.S. retail sales, Stellantis North America.
Stellantis was anticipated to be the lowest-performing automaker in terms of sales during the third quarter, <a target="_blank" href="https://www.cnbc.com/2024/10/02/stellantis-us-auto-sales-extend-freefall-in-third-quarter.html" rel="noreferrer noopener">reported </a>CNBC. Industry forecaster Cox Automotive had estimated a sales drop of approximately 21% for the company, per the report.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41144884/fords-us-sales-edge-up-in-q3-ev-sales-continue-to-climb" rel="noreferrer noopener">Ford&#8217;s US Sales Edge Up In Q3; EV Sales Continue To Climb</a>
FCA US LLC&#8217;s total market share increased consecutively during the third quarter, rising from 7.2% in July to 8% in September, while inventory was reduced by 50K units.
Incentive offerings will continue through the end of the year across the U.S. brand portfolio, which includes Chrysler, Dodge, FIAT, Jeep, and Ram, Stellantis said.
&#8220;We continue to take the necessary actions to drive sales and prepare our dealer network and consumers for the arrival of 2025 models,&#8221; added Thompson.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, STLA stock has lost over 28% in the past year.
Price Action: STLA shares are trading lower by 0.69% to $13.62 at last check Wednesday.
Photo by Jonathan Weiss on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41145482/whats-going-on-with-mullen-automotive-stock-today" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Mullen Automotive Stock Today?</a></li>
</ul>

Equities

Markets

Movers

General

STLA

Chrysler Parent Stellantis' US Sales Nosedive 20% In Q3: Details Here

Following a 5% drop on Tuesday, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is down 0.3% to $61,680 on Wednesday afternoon, with analysts cautioning traders about potential further downside if <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41145355/bitcoin-bulls-should-watch-this-crucial-level-10x-research">key support levels don&#8217;t hold</a>.
What Happened: Alex Kuptsikevich, senior market analyst at FxPro said a technical factor added to the selling: the day before, BTCUSD had fallen below its 200-day moving average, reinforcing the exit of &#8216;weak hands&#8217; from the asset.
Experts are closely watching the $60,918 level, which represents the 21-week moving average. 
According to a report, if Bitcoin trades below this level, traders should consider reducing their long positions.
The cryptocurrency market as a whole has seen a significant correction, with the total market capitalization dropping 4.2% in the last 24 hours to $2.16 trillion. 
Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), the second-largest cryptocurrency, is down 1.5% at $2,449.
&#8220;Bitcoin found local support as it approached its 50-day moving average just above $60.3K. Geopolitics seem to have interfered with the bullish trade, pushing Bitcoin away from the upper boundary of the multi-month channel,&#8221; Kuptsikevich said in a note to Benzinga.
The market downturn coincides with escalating <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41126018/bitcoin-plunges-below-62k-as-iran-launches-missile-attack-on-israel">geopolitical tensions in the Middle East</a>.
The Israel Defense Forces (IDF) reported that over 100 missiles have been launched into Israel from Iran, with sirens sounding in Tel Aviv and Jerusalem.
This geopolitical unrest has impacted not only cryptocurrencies but also traditional markets, with Kuptsikevich noting, &#8220;Cryptocurrencies took a hit along with risk assets, while the dollar, gold and oil rose sharply.&#8221;
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41142958/ripple-etf-could-it-happen-bitwises-filing-faces-uncertain-path-amid-regulatory-concerns">Ripple ETF: Could It Happen? Bitwise&#8217;s Filing Faces Uncertain Path Amid Regulatory Concerns</a>
Why It Matters: The recent price action has also affected Bitcoin and Ethereum spot ETFs.
On Oct. 1, Bitcoin spot ETFs experienced a total net outflow of $243 million, marking the first net outflow after eight consecutive days of inflows.
Fidelity&#8216;s (CBOE: FBTC) saw an outflow of $144 million, while (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKB#BATS">ARKB</a>) outflowed $84.35 million. 
BlackRock&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) ETF, however, saw an inflow of $40.8 million, <a href="https://sosovalue.xyz/assets/etf/us-btc-spot">according</a> to data from SoSo Value.
Ethereum spot ETFs also faced outflows, with a total net outflow of $48.5 million on the same day. 
(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETHE#NYSE">ETHE</a>) and (CBOE: FETH) experienced outflows of $26.6 million and $24.9 million respectively.
Despite the current market turbulence, some analysts remain optimistic about the long-term prospects of cryptocurrencies. 
Samir Kerbage, Chief Investment Officer at Hashdex, highlighted the growing political significance of crypto: &#8220;Crypto being part of the political conversation, especially coming from vice-presidential candidates in the United States, is a positive development. It&#8217;s a big step forward compared to a year or 18 months ago.&#8221;
Kerbage also emphasized the emergence of the &#8220;crypto voter&#8221; and its potential impact on the upcoming U.S. elections. 
&#8220;This growing political influence is something I wrote about earlier this year, and I continue to believe that this technology, like the internet, is not political by nature and will over time become less partisan,&#8221; he said in a note to Benzinga.
What&#8217;s Next: As the crypto market navigates through these uncertain times, investors and enthusiasts alike are looking forward to events such as Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41141962/remember-sbfs-i-didnt-stash-billions-away-the-latest-ftx-repayment-update-may-have-other-ideas">Remember SBF&#8217;s &#8216;I Didn&#8217;t Stash Billions Away&#8217;? The Latest FTX Repayment Update May Have Other Ideas</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

ETHE

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

IBIT

Bitcoin Drops Below $62,000 As Analysts Warn Of Potential Further Decline

Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) has outperformed the market over the past 5 years by 3.78% on an annualized basis producing an average annual return of 18.29%. Currently, Qualcomm has a market capitalization of $187.91 billion. 
Buying $100 In QCOM: If an investor had bought $100 of QCOM stock 5 years ago, it would be worth $220.99 today based on a price of $168.68 for QCOM at the time of writing.
<h3>Qualcomm's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727890357_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

QCOM

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) has outperformed the market over the past 5 years by 1.0% on an annualized basis producing an average annual return of 15.5%. Currently, Williams Companies has a market capitalization of $57.41 billion. 
Buying $1000 In WMB: If an investor had bought $1000 of WMB stock 5 years ago, it would be worth $2,005.96 today based on a price of $47.10 for WMB at the time of writing.
<h3>Williams Companies's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727890352_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today

LPL Financial Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpla#NASDAQ">LPLA</a>), along with its subsidiaries LPL Financial LLC, has completed the acquisition of Altria Wealth Solutions, Inc. (&quot;Altria&quot;). Further, the company announced a change in its leadership with the termination of its existing president and chief executive officer&nbsp;and the appointment of a new CEO.
<h2>Details of Acquisition Pursued by LPLA</h2>
Atria Wealth Solutions, Inc., based in New York, boasts a network of almost 2,400 advisors and serves around 150 banks and credit unions, managing an impressive $100 billion in brokerage and advisory assets. Notably, brokerage accounts comprise nearly 80% of the firm&#39;s assets, with the rest in advisory holdings.
Per the acquisition announcement dated Feb. 13, 2024, LPLA expected onboarding and integration costs to be between $300 million and $350 million. Despite these expenses, the long-term financial projections are promising, with LPLA anticipating additional earnings of $140 million annually from the deal.
LPL Financial expects to meet or exceed its retention target of 80%. Altria will function as a wholly owned portfolio company through the onboarding of Altria advisors, which is anticipated to be completed in mid-2025.
The acquisition aligns with LPL Financial&#39;s goal to empower independent financial advisors and institutions nationwide by providing them with comprehensive support and resources. The acquisition of Atria Wealth Solutions builds upon LPL Financial&#39;s previous successful ventures, including the acquisition of National Planning Holdings and Waddell &amp; Reed in 2017 and 2021, respectively.
Further, LPLA considers acquisitions a core part of its business expansion strategy. In May, the company acquired Crown Capital, while in September, it agreed to acquire The Investment Center, Inc., reinforcing its strategy of expanding its advisor network and enhancing offerings.
<h2>LPL Financial Leadership Change</h2>
LPLA&#39;s board of directors terminated the company&#39;s president and chief executive officer, Dan H. Arnold for violation of the company&#39;s commitment to a respectful workplace. He has submitted his resignation from the board as well.
The dismissal is based on the cause recommended by a special committee of directors following an investigation by an external law firm, which concluded that Arnold had made statements to employees that breached LPLA&#39;s code of conduct.
The board has appointed Rich Steinmeier (presently the company&#39;s managing director and chief growth officer) as interim CEO, effective immediately.
James Putnam, chair of the board of directors at LPL Financial, stated, &quot;LPL&#39;s Code of Conduct requires every employee, no matter their title, to foster a supportive and professional workplace and show respect to each other, our stakeholders and the broader community, Mr. Arnold failed to meet these obligations.&quot;
<h2>LPL Financial&#39;s Zacks Rank &amp; Price Performance</h2>
Year to date, shares of LPL Financial have risen 1% compared with the industry&#39;s growth of 17.7%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/4d/79979.jpg?v=1650055316" />
Image Source: Zacks Investment Research
Currently, LPLA carries a Zacks Rank #3 (Hold).
<h2>Merger &amp; Acquisition Deal Pursued by Other Finance Firms</h2>
This week, Byline Bancorp, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/by#NYSE">BY</a>) entered into a cash and stock merger deal worth $41 million with First Security Bancorp, Inc. in an effort to strengthen its position in Chicago.
The merger is expected to solidify Byline&#39;s position as Chicago&#39;s largest community bank, with assets under $10 billion, loans of $7.3 billion and deposits worth $7.8 billion, along with 45 branches across the greater Chicago metropolitan area.
Last week, TowneBank (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/town#NASDAQ">TOWN</a>) agreed to acquire Village Bank and Trust Financial Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vbfc#NASDAQ">VBFC</a>). The all-cash transaction is valued at $120 million.
The deal is anticipated to be roughly 6% accretive to TOWN&#39;s 2025 earnings per share, assuming the execution of cost savings on a GAAP basis. Further, TOWN projects a roughly 1% improvement in common equity tier 1 capital and an 80-basis points improvement in efficiency ratio next year.
<a href="https://www.zacks.com/stock/news/2344611/lpl-financial-acquires-altria-wealth-solutions-appoints-new-ceo?cid=CS-BENZ-FT-analyst_blog|company_news_finance_sector-2344611">To read this article on Zacks.com click here.</a>

Earnings

Large Cap

Mid Cap

Offerings

Small Cap

Events

LPLA

TOWN

VBFC

LPL Financial Acquires Altria Wealth Solutions, Appoints New CEO

BTIG analyst Mark Massaro maintains Adaptive Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) with a Buy and raises the price target from $7 to $8.

ADPT

BTIG Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $8

WIIM

MTRN

Materion shares are trading lower. Seaport Global cut its price target on the stock from $150 to $135.

Orchid Island Cap's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORC#NYSE">ORC</a>) short percent of float has fallen 12.94% since its last report. The company recently reported that it has 3.48 million shares sold short, which is 4.71% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.09 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Orchid Island Cap Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727890224_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Orchid Island Cap has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Orchid Island Cap's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Orchid Island Cap's peer group average for short interest as a percentage of float is 7.14%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Orchid Island Cap?

Futu Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NYSE">FUTU</a>) short percent of float has risen 3.6% since its last report. The company recently reported that it has 4.31 million shares sold short, which is 4.32% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.18 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Futu Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727890219_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Futu Hldgs has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Futu Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Futu Hldgs's peer group average for short interest as a percentage of float is 3.28%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

FUTU

How Is The Market Feeling About Futu Hldgs?

Mizuho analyst Paul Fremont maintains Eversource Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ES#NYSE">ES</a>) with a Outperform and raises the price target from $62 to $73.

Mizuho Maintains Outperform on Eversource Energy, Raises Price Target to $73

Encompass Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) short percent of float has fallen 9.03% since its last report. The company recently reported that it has 1.16 million shares sold short, which is 1.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.81 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Encompass Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727890214_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Encompass Health has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Encompass Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Encompass Health's peer group average for short interest as a percentage of float is 3.94%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Encompass Health's Recent Short Interest

<a href="https://www.theinformation.com/briefings/openai-employees-may-get-to-sell-shares-after-6-6-billion-round-says-cfo" title="https://www.theinformation.com/briefings/openai-employees-may-get-to-sell-shares-after-6-6-billion-round-says-cfo">https://www.theinformation.com/briefings/openai-employees-may-get-to-sell-shares-after-6-6-billion-round-says-cfo</a>

MSFT

NVDA

'OpenAI Employees May Get to Sell Shares After $6.6B Round, Says CFO' - The Information

Sen. Ron Wyden (D-OR) made headlines a week ago after <a href="https://www.benzinga.com/markets/cannabis/24/09/41069354/synthetic-cannabinoids-could-be-federally-banned-under-new-senate-bill-to-regulate-hemp-derived-">introducing</a> the Cannabinoid Safety and Regulation Act (CSRA), a measure that seeks to set up a federal framework for regulating hemp-derived cannabinoids like <a href="https://www.benzinga.com/topic/CBD">CBD</a> and <a href="https://www.benzinga.com/markets/cannabis/24/01/36584043/real-weed-or-a-lab-high-delta-8-and-delta-9-thc-explained">Delta-8 THC</a>.
On Wednesday, ONE HEMP hailed Congressional action toward the regulation of CBD as a dietary supplement, calling the move "long overdue."
The coalition of industry leaders was committed to advancing regulatory standards for hemp-derived cannabinoid (CBD) products for years.
&#8220;ONE HEMP has been deeply committed to a bipartisan legislative process and has worked closely with Congressional leaders on both sides of the political aisle to provide scientific and market expertise," said Kelly D. Fair, ONE HEMP counsel and partner at Dentons US. &#8220;The Wyden bill marks the beginning of a process that will ultimately lead to an approach that will promote a vibrant CBD industry and ensure access for millions of consumers to the highest quality and safest CBD products.&#8221; 
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/02104055/ccc-oct-24-banner__1_-1-2.gif" alt="" class="wp-image-576699" /></a></figure>
ONE HEMP added the legislative effort is a result of collaborative work between industry leaders, highlighting Charlotte&#8217;s Web's (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CWEB#TSX">CWEB</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTCQX">CWBHF</a>) participation. The medical cannabis pioneer has been at the forefront of advancing FDA-level regulatory standards for more than a decade, the organization said.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/39820619/strategy-shift-in-the-works-are-cannabis-giants-getting-into-the-hemp-derived-thc-market">Strategy Shift In The Works? Are Cannabis Giants Getting Into The Hemp Derived-THC Market?</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Bill Morachnick, CEO of Charlotte&#8217;s Web, praised the legislative milestone, calling the CSRA "a critical step for the CBD industry."
&#8220;Charlotte&#8217;s Web is proud to be joined together with other CBD industry leaders as part of ONE HEMP to provide the support Congress needs to ensure the best possible path forward for our industry, and, more importantly, the millions of consumers who rely on our products,&#8221; Morachnick added.
The company, which has been at the forefront of CBD <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4262186-1&amp;h=3519445035&amp;u=https%3A%2F%2Fwww.charlottesweb.com%2Fall-charlottes-web-hemp-cbd-supplements&amp;a=hemp+extract+wellness+products">hemp extract wellness products</a> space for years, expressed strong opposition to the new regulations in California that restrict the sale of many ingestible full-spectrum hemp CBD products that meet federal requirements.
Morachnick said Governor <a href="https://www.benzinga.com/topic/gavin-newsom">Gavin Newsom</a>‘s <a href="https://www.benzinga.com/markets/cannabis/24/09/41012794/gov-newsoms-hemp-ban-goes-into-effect-consequences-for-industry-investors-patients">emergency ban</a> on all hemp-derived THC products in the Golden State, which recently went into effect is &#8220;overreaching and unnecessarily restrict access to safe, non-intoxicating hemp products."
He is not against the regulation of synthetic and intoxicating products though. ONE HEMP is of the same stance.
"This Congressional step [CSRA] comes at a critical time, as the vacuum of federal regulation in the wake of the 2018 Farm Bill has been filled by intoxicating hemp-derived synthetic cannabinoid products being presented to consumers in the market as CBD, leading states to act – and often unduly capturing non-intoxicating CBD products," the coalition said in a press release.
Read Next:
<a href="https://www.benzinga.com/markets/cannabis/24/09/40906131/this-is-life-or-death-families-of-disabled-children-panic-over-gov-newsoms-hemp-cbd-ban-and-eval">‘This Is Life Or Death': Families Of Disabled Children Panic Over Gov. Newsom's Hemp CBD Ban And Evaluate Lawsuit</a>

Cannabis

Government

Regulations

Politics

CWBHF

CWEB

TSX:CWEB

Congressional Bill Is Game-Changer For CBD Regulation, It's 'Long Overdue,' Says Hemp Coalition

Macro Economic Events

Economics

OPEC Says, Regarding WSJ Report About Saudi Saying Oil May Drop To $50 If OPEC+ Flouts Output Curbs, It Refutes Story's Claims As 'Wholly Inaccurate And Misleading'

Summit Midstream shares are trading higher. The company announced it will acquire Tall Oak Midstream Operating, LLC and its subsidiaries from an affiliate of Tailwater Capital for $155 million in cash plus common stock.

Alliance Global Partners analyst Brian Kinstlinger maintains LiveOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVO#NASDAQ">LVO</a>) with a Buy and lowers the price target from $3.5 to $1.5.

Alliance Global Partners Maintains Buy on LiveOne, Lowers Price Target to $1.5

Mizuho analyst Gabriel Moreen maintains USA Compression Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USAC#NYSE">USAC</a>) with a Neutral and lowers the price target from $25 to $24.

USAC

Mizuho Maintains Neutral on USA Compression Partners, Lowers Price Target to $24

Macquarie analyst Paul Golding maintains Vail Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) with a Neutral and maintains $180 price target.

Macquarie Maintains Neutral on Vail Resorts, Maintains $180 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers as we start the trading week on Monday!



Moving stocks this morning are acquisition deals, a lunar mission plan, insider trading and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Miromatrix Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/miro-stock-quote/">MIRO</a>) stock is rocketing more than 224% after <a href="https://finance.yahoo.com/news/united-therapeutics-acquire-miromatrix-medical-100500482.html">announcing an acquisition deal</a> with United Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/uthr-stock-quote/">UTHR</a>).</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) shares are soaring over 71% alongside heavy pre-market trading.</li>



<li>Investcorp India Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/ivca-stock-quote/">IVCA</a>) stock is surging more than 32% on Monday morning.</li>



<li>ReAlpha Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/aire-stock-quote/">AIRE</a>) shares are rising close to 22% this morning.</li>



<li>Motus GI (NASDAQ:<a href="https://investorplace.com/stock-quotes/mots-stock-quote/">MOTS</a>) stock is increasing nearly 22% despite a lack of news this morning. </li>



<li>Eyenovia (NASDAQ:<a href="https://investorplace.com/stock-quotes/eyen-stock-quote/">EYEN</a>) shares are gaining over 15% without any clear news on Monday morning.</li>



<li>NeuBase Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nbse-stock-quote/">NBSE</a>) stock is climbing 15% today.</li>



<li>Coherus BioSciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/chrs-stock-quote/">CHRS</a>) shares are heading more than 14% higher alongside Food and Drug Administration (FDA) <a href="https://www.morningstar.com/news/dow-jones/2023102711074/coherus-biosciences-shares-climb-12-on-fda-approval-for-cancer-treatment-loqtorzi">approval for its cancer treatment</a>.</li>



<li>Intuitive Machines (NASDAQ:<a href="https://investorplace.com/stock-quotes/lunr-stock-quote/">LUNR</a>) stock is jumping over 11% after announcing plans for a <a href="https://seekingalpha.com/news/4026033-intuitive-machines-targets-january-2024-for-us-lunar-mission-stock-skyrockets">January 2024 lunar mission</a>.</li>



<li>Spirit Realty Capital (NYSE:<a href="https://investorplace.com/stock-quotes/src-stock-quote/">SRC</a>) shares are up almost 11% after agreeing to a <a href="https://www.marketwatch.com/story/spirit-realty-stock-rallies-on-9b-buyout-by-realty-income-corp-e65e2e1d">$9 billion acquisition deal</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>BIO-key International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bkyi-stock-quote/">BKYI</a>) stock is plummeting more than 23% as it comes off of a recent rally.</li>



<li>Fangdd Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/duo-stock-quote/">DUO</a>) shares are diving 15% on Monday morning. </li>



<li>Nuvve (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvve-stock-quote/">NVVE</a>) stock is tumbling over 14% <a href="https://finance.yahoo.com/news/co-founder-nuvve-holding-picks-120628360.html">despite recent insider buying</a>.</li>



<li>Medicenna Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdna-stock-quote/">MDNA</a>) shares are taking a more than 13% beating <a href="https://finance.yahoo.com/news/medicenna-announces-nasdaq-delisting-cutback-115500662.html">alongside delisting news</a>.</li>



<li>Vaxart (NASDAQ:<a href="https://investorplace.com/stock-quotes/vxrt-stock-quote/">VXRT</a>) stock is falling over 10% on Monday morning.</li>



<li>Vivopower International (NASDAQ:<a href="https://investorplace.com/stock-quotes/vvpr-stock-quote/">VVPR</a>) stock is dropping close to 10% on Monday morning.</li>



<li>NeuroOne Medical Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmtc-stock-quote/">NMTC</a>) shares are sliding more than 9% this morning.</li>



<li>Bit Brother (NASDAQ:<a href="https://investorplace.com/stock-quotes/bets-stock-quote/">BETS</a>) stock is decreasing over 9% with strong early morning trading.</li>



<li>PaxMedica (NASDAQ:<a href="https://investorplace.com/stock-quotes/pxmd-stock-quote/">PXMD</a>) shares are slipping more than 9% this morning.</li>



<li>Harpoon Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/harp-stock-quote/">HARP</a>) stock closes out our pre-market movers down nearly 9% even with <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317825670&amp;type=PDF&amp;symbol=HARP&amp;cdn=bd60de3e71fd9f6cae32bddc1d2439f1&amp;companyName=Harpoon+Therapeutics+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2023-10-27">insider buying news</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
		<div>
			<div></div>
						<div></div>
					</div>
	</div>The post <a href="https://investorplace.com/2023/10/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-oct-30th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Earnings week ahead: Salesforce, Costco, Canopy Growth, Dell,  Dollar General, and more

Catalyst Watch: Eyes on Walmart earnings, the July CPI print, and 13F filings

Wall Street Breakfast: The Week Ahead

Investcorp India Acquisition Corp. Class A ( ($IVCA) ) has issued an announcement. Bigtincan Holdings Limited has caught the attention of Investcor...

Investcorp Proposes $275M Business Combination with Bigtincan

AAPL

AFMD

AIRE

ALBT

AMAT

AMBA

AMSC

AMZN

APPS

ARDT

ARTV

ASAN

ATXS

BABA

BDTX

BETS

BKYI

BLRX

BURL

BZUN

CANG

CAVA

CHGG

CHRO

CHRS

CHUY

CHWY

CIFR

CMPX

COIN

CONN

COST

CPRI

CRUS

CRWD

CSCO

CTXR

DAVE

DELL

DESP

DKNG

ENVA

ESLT

ESTC

EYEN

FFIE

FIVE

FLUT

FWRD

GLMD

GLNG

GLST

GOLD

GOOG

GOOGL

GTHX

HARP

IDXX

ILMN

INTC

ISPO

IVCA

LUMN

LUNR

MAXN

MDNA

MIRO

MLAB

MNDY

MOMO

MOTS

MRVL

MSCI

NBSE

NCNO

NMTC

NNOX

NTAP

NTNX

NVVE

OKLO

OKTA

ONON

PATH

PGNY

PINS

PSTG

PXMD

QLGN

SAVA

SAVE

SMCI

SNAP

SPGC

SPRY

SSNLF

SSYS

TSLA

TWFG

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Investcorp India

News

Latest news for Investcorp India (NASDAQ:IVCA) Stock